MRI-derived radiogenomic surrogate of a hypoxia–angiogenesis–EMT transcriptional state in nasopharyngeal carcinoma: multicenter external validation
Abstract
BackgroundThis study aimed to develop a pretreatment MRI-derived radiogenomic surrogate of a prespecified hypoxia–angiogenesis–epithelial–mesenchymal transition transcriptional state and to evaluate its associations with treatment response and survival in nasopharyngeal carcinoma.MethodsThis multicenter observational study integrated patient-derived public transcriptomic datasets, experimental CNE2/CNE2-IR radioresistance models, a prospective RNA-sequencing cohort of 49 patients with paired contrast-enhanced T1-weighted MRI and RNA data, and two independent clinical cohorts (n = 532 and n = 118). HAE-CAS was the equal-weight mean of three within-cohort standardized module scores. Treatment response was assessed approximately 3 months after chemoradiotherapy according to RECIST version 1.1 using nasopharyngeal MRI, nasopharyngoscopy, and clinical evaluation. Rad-HAE used a five-feature Gaussian ridge model and was evaluated with 20 repetitions of five-fold nested cross-validation; response and survival outcomes were excluded from model development.ResultsAmong 49 response-evaluable RNA-sequenced patients, 17 had complete response (CR) and 32 had partial response (PR); no stable or progressive disease occurred. HAE-CAS was higher in PR than CR (rank-biserial correlation = 0.365, P = 0.035). In GSE102349, continuous HAE-CAS was not significantly associated with progression-free survival (HR per 1-SD increase = 1.20, 95% CI 0.74–1.95; P = 0.465), whereas the median-dichotomized comparison was exploratory (log-rank P = 0.024). Aggregated out-of-fold Rad-HAE correlated with HAE-CAS (Spearman rho = 0.637, P < 0.001) and discriminated PR from CR among 49 paired response-evaluable patients (AUC = 0.846, 95% CI 0.732–0.943). In two independent clinical cohorts, higher Rad-HAE was associated with shorter progression-free and overall survival.ConclusionPretreatment CE-T1WI radiomics was associated with interpatient variation in a prespecified composite HAE transcriptional state. Rad-HAE represents an imaging-based surrogate associated with the composite HAE transcriptional state and does not directly quantify individual biological processes.
Related
- CT-derived nested habitats score for preoperative IASLC grading in lung adenocarcinoma: cross-center validation and radiogenomic analysis
- Computational Modeling of Vasculogenesis and Angiogenesis as Emergent Processes for the Design of Tissue Engineering Strategies
- A collagen Vα1-derived fragment inhibits FGF-2 induced-angiogenesis by modulating endothelial cells plasticity through its heparin-binding site
- MambaGLA-NPC: a 3D framework integrating CNN and state space models for robust multi-center nasopharyngeal carcinoma segmentation
- A nematic framework for sprouting angiogenesis
BibTeX
@article{zuo2026mriderived,
title = {{MRI-derived radiogenomic surrogate of a hypoxia–angiogenesis–EMT transcriptional state in nasopharyngeal carcinoma: multicenter external validation}},
author = {Zhichao Zuo and Ting Zhu and Yixin Lu and Xiaoyi Zeng and Yang Liu},
journal = {Frontiers in Molecular Biosciences},
year = {2026},
month = nov,
doi = {10.3389/fmolb.2026.1968989},
url = {https://www.frontiersin.org/articles/10.3389/fmolb.2026.1968989},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - MRI-derived radiogenomic surrogate of a hypoxia–angiogenesis–EMT transcriptional state in nasopharyngeal carcinoma: multicenter external validation
AU - Zhichao Zuo
AU - Ting Zhu
AU - Yixin Lu
AU - Xiaoyi Zeng
AU - Yang Liu
PY - 2026
DA - 2026/11/05
JO - Frontiers in Molecular Biosciences
DO - 10.3389/fmolb.2026.1968989
UR - https://www.frontiersin.org/articles/10.3389/fmolb.2026.1968989
AB - BackgroundThis study aimed to develop a pretreatment MRI-derived radiogenomic surrogate of a prespecified hypoxia–angiogenesis–epithelial–mesenchymal transition transcriptional state and to evaluate its associations with treatment response and survival in nasopharyngeal carcinoma.MethodsThis multicenter observational study integrated patient-derived public transcriptomic datasets, experimental CNE2/CNE2-IR radioresistance models, a prospective RNA-sequencing cohort of 49 patients with paired contrast-enhanced T1-weighted MRI and RNA data, and two independent clinical cohorts (n = 532 and n = 118). HAE-CAS was the equal-weight mean of three within-cohort standardized module scores. Treatment response was assessed approximately 3 months after chemoradiotherapy according to RECIST version 1.1 using nasopharyngeal MRI, nasopharyngoscopy, and clinical evaluation. Rad-HAE used a five-feature Gaussian ridge model and was evaluated with 20 repetitions of five-fold nested cross-validation; response and survival outcomes were excluded from model development.ResultsAmong 49 response-evaluable RNA-sequenced patients, 17 had complete response (CR) and 32 had partial response (PR); no stable or progressive disease occurred. HAE-CAS was higher in PR than CR (rank-biserial correlation = 0.365, P = 0.035). In GSE102349, continuous HAE-CAS was not significantly associated with progression-free survival (HR per 1-SD increase = 1.20, 95% CI 0.74–1.95; P = 0.465), whereas the median-dichotomized comparison was exploratory (log-rank P = 0.024). Aggregated out-of-fold Rad-HAE correlated with HAE-CAS (Spearman rho = 0.637, P < 0.001) and discriminated PR from CR among 49 paired response-evaluable patients (AUC = 0.846, 95% CI 0.732–0.943). In two independent clinical cohorts, higher Rad-HAE was associated with shorter progression-free and overall survival.ConclusionPretreatment CE-T1WI radiomics was associated with interpatient variation in a prespecified composite HAE transcriptional state. Rad-HAE represents an imaging-based surrogate associated with the composite HAE transcriptional state and does not directly quantify individual biological processes.
SN - 2296-889X
ER -